H19 and chronic myelogenous leukemia, BCR-ABL1 positive: However, the potential linkage between H19 or its derived miR-675 and CML drug response has not yet been reported; hence H19/miR-675 have become the initial targets of our investigation in CML therapeutic resistance and subsequently led to the further exploration of their interaction with the newly identified lncRNA target.